Omnicell (OMCL) Common Equity (2010 - 2026)

Omnicell (OMCL) has reported Common Equity for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 2.21% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 2.21% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, down 0.92% from the prior year.
• Common Equity was $1.3 billion for Q2 2026 at Omnicell, up from $1.3 billion in the prior quarter.
• Over five years, Common Equity peaked at $1.3 billion in Q2 2026 and troughed at $1.1 billion in Q1 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity declined 1.44% in 2022 and rose 6.49% in 2023, its largest moves.
• Over 5 years, Common Equity stood at $1.1 billion in 2022, then gained by 5.2% to $1.2 billion in 2023, then grew by 4.57% to $1.2 billion in 2024, then decreased by 0.92% to $1.2 billion in 2025, then rose by 4.85% to $1.3 billion in 2026.
• The last three Common Equity figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.